Dulaglutide for treating type 2 diabetes in children and young people TS ID 10660Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Aflibercept for untreated diabetic macular oedema TS ID 10621Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Semaglutide for treating type 2 diabetes and associated peripheral arterial disease TS ID 11791Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Empagliflozin with linagliptin for treating type 2 diabetes in people aged 10 to 17 TS ID 11818Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
LY3209590 for treating type 2 diabetes in people on daily insulin injections TS ID 11837Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
LY3209590 for treating type 1 diabetes in people on multiple daily insulin injections TS ID 11836Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC